Back to search
FDAFDA · Food and drugs·Recall number D-0143-2017

NIFEdipine Capsules USP, 10 mg, Rx only, 100 count bottle, Manufactured and distributed by: Actavis Elizabeth LLC, 200 Elmora Avenue, Elizabeth, NJ 07207, NDC 0228-2407-10

Published November 30, 2016 · Recall initiated: October 6, 2016

Summary

FDA records drug Class III recall D-0143-2017, published November 30, 2016 and initiated October 6, 2016. Recalling firm: Actavis Elizabeth LLC; Status: Terminated; Reported quantity: 27,517 bottles; Lot: Lot # 0598B151; Exp 03/18. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Actavis Elizabeth LLC
Distributor
US
Lot
Lot # 0598B151; Exp 03/18
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was NIFEdipine Capsules USP, 10 mg, Rx only, 100 count bottle, Manufactured and distributed by: Actavis Elizabeth LLC, 200 Elmora Avenue, Elizabeth, NJ 07207, NDC 0228-2407-10 recalled?

Yes. FDA published recall D-0143-2017 on November 30, 2016. Reported hazard: Presence of Foreign Tablets/Capsules

What should I do if I have this product?

Voluntary: Firm initiated · Letter